Exforge HCT Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Each film-coated tablet contains 5 mg of amlodipine (as amlodipine besylate), 160 mg of valsartan and 12.5 mg of hydrochlorothiazide.
Each film-coated tablet contains 10 mg of amlodipine (as amlodipine besylate), 160 mg of valsartan and 12.5 mg of hydrochlorothiazide.
Each film-coated tablet contains 10 mg of amlodipine (as amlodipine besylate), 160 mg of valsartan and 25 mg of hydrochlorothiazide.
Excipients/Inactive Ingredients: Tablet core: Cellulose microcrystalline, Crospovidone, Colloidal anhydrous silica, Magnesium stearate.
Coating (Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets): Hypromellose, Macrogol 4000, Talc, Titanium dioxide (E171).
Coating (Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets): Hypromellose, Macrogol 4000, Talc, Titanium dioxide (E171), Yellow iron oxide (E172) Red iron oxide (E172).
Coating (Exforge HCT 10 mg/160 mg/25 mg film-coated tablets): Hypromellose, Macrogol 4000, Talc, Yellow iron oxide (E172).

Manufacturer:

Novartis

Distributor:

Zuellig